Stocks to watch on Tuesday: CE, IEX, SONC >>> READ MORE

AMGN

Recent Articles

Industry Group Rank Metrics Keep Amgen (AMGN) Ratings Upgrade to Hold

Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical. More 

Amgen’s (AMGN) Raised to Hold

Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using the methods of Louis Navellier for investing and his Portfolio Grader stock evaluator. The shares have been upgraded from a Sell to a Hold in the last week. More 

How Will Trump’s Proposed Tax Reform Impact Drug Companies?

Donald Trump has proposed new tax reforms for individuals and corporates. Let’s see how the reforms, if passed, will impact pharma companies. More 

Trade of the Day: Amgen, Inc. (AMGN) Stock Has Plenty More Upside

AMGN stock is higher by just about 27% for the year-to-date, but in the bigger picture Amgen really just started on a new breakout rally. More 

SPDR S&P Biotech (ETF) (XBI): The Quick Guide to XBI

Biotechnology investors have turned the equal-weight SPDR S&P Biotech ETF (XBI) into one of the largest sector plays. Is it right for you? More 

Supercharge Your Portfolio With Amgen, Inc. (AMGN) Stock

Wall Street goes on buying sprees into the biotech sector. Take advantage of this run to profit from red hot AMGN Stock. It's headed higher. More 

3 Large-Cap Biotech Stocks to Scrape From the Selloff

Large-cap biotech stocks like Regeneron, Celgene and Amgen are offering value both on and off the price chart. Here's how to profit. More